Skip to main content
Erschienen in: Digestive Diseases and Sciences 8/2010

01.08.2010 | Original Article

Purified Micronized Flavonoid Fraction Ameliorates the Injury of Spleen and Ileum Secondary to Hepatic Ischemia–Reperfusion in Rats

verfasst von: Fahrettin Yildiz, Alpaslan Terzi, Sacit Coban, Muharrem Bitiren, Hakim Celik, Nurten Aksoy, Mustafa Kemal Ozdogan, Hale Cakir

Erschienen in: Digestive Diseases and Sciences | Ausgabe 8/2010

Einloggen, um Zugang zu erhalten

Abstract

Background

Flavonoids have been subjected to considerable investigations due to their antioxidant and anti-inflammatory properties. Yet the effects of flavonoids on the ileum and spleen against hepatic ischemia–reperfusion injury have so far not been addressed.

Aims

We aimed to investigate whether micronized purified flavonoid fraction (MPFF) protects the ileum and spleen against hepatic ischemia–reperfusion injury.

Methods

Rats were subjected to hepatic ischemia by clamping the hilar area of the rats for 60 min, followed by 60 min of reperfusion. Rats in the treatment group were treated with MPFF (80 mg/kg/day) by gavage for 3 days before surgery, 30 min prior to ischemia and just before the reperfusion. After the reperfusion period, all rats were sacrificed. Ileal and splenic tissues were taken for histological evaluation and determination of the total antioxidant capacity (TAC), catalase, total oxidant status (TOS), oxidative stress index (OSI) and myeloperoxidase (MPO) levels.

Results

TAC levels in the splenic tissue and intestinal tissue were significantly higher in the treatment group than in the control group (P < 0.01 for both). TOS, OSI, and MPO in splenic tissue (P < 0.01, P < 0.05, and P < 0.05, respectively) and intestinal tissue (P < 0.01, P < 0.01, and P < 0.001, respectively) were significantly lower in the treatment group than in the control group. Histological tissue damage of intestinal tissue was milder in the treatment group than in the control group.

Conclusion

The results of this study indicated that MPFF pretreatment significantly limited the injury to the small intestine and spleen induced by hepatic ischemia–reperfusion in rats.
Literatur
1.
Zurück zum Zitat Patel S, Pachter HL, Yee H, Schwartz JD, Marcus SG, Shamamian P. Topical hepatic hypothermia attenuates pulmonary injury after hepatic ischemia and reperfusion. J Am Coll Surg. 2000;191(6):650–656.CrossRefPubMed Patel S, Pachter HL, Yee H, Schwartz JD, Marcus SG, Shamamian P. Topical hepatic hypothermia attenuates pulmonary injury after hepatic ischemia and reperfusion. J Am Coll Surg. 2000;191(6):650–656.CrossRefPubMed
2.
Zurück zum Zitat Meyer K, Brown MF, Zibari G, et al. ICAM-1 upregulation in distant tissues after hepatic ischemia/reperfusion: a clue to the mechanism of multiple organ failure. J Pediatr Surg. 1998;33(2):350–353.CrossRefPubMed Meyer K, Brown MF, Zibari G, et al. ICAM-1 upregulation in distant tissues after hepatic ischemia/reperfusion: a clue to the mechanism of multiple organ failure. J Pediatr Surg. 1998;33(2):350–353.CrossRefPubMed
3.
Zurück zum Zitat Montalvo-Jave EE, Escalante-Tattersfield T, Ortega-Salgado JA, Piña E, Geller DA. Factors in the pathophysiology of the liver ischemia–reperfusion injury. J Surg Res. 2008;147(1):153–159.CrossRefPubMed Montalvo-Jave EE, Escalante-Tattersfield T, Ortega-Salgado JA, Piña E, Geller DA. Factors in the pathophysiology of the liver ischemia–reperfusion injury. J Surg Res. 2008;147(1):153–159.CrossRefPubMed
4.
Zurück zum Zitat Pulitanò C, Aldrighetti L. The protective role of steroids in ischemia–reperfusion injury of the liver. Curr Pharm Des. 2008;14(5):496–503.CrossRefPubMed Pulitanò C, Aldrighetti L. The protective role of steroids in ischemia–reperfusion injury of the liver. Curr Pharm Des. 2008;14(5):496–503.CrossRefPubMed
5.
Zurück zum Zitat Shen SQ, Zhang Y, Xiang JJ, Xiong CL. Protective effect of curcumin against liver warm ischemia/reperfusion injury in rat model is associated with regulation of heat shock protein and antioxidant enzymes. World J Gastroenterol. 2007;13(13):1953–1961.PubMed Shen SQ, Zhang Y, Xiang JJ, Xiong CL. Protective effect of curcumin against liver warm ischemia/reperfusion injury in rat model is associated with regulation of heat shock protein and antioxidant enzymes. World J Gastroenterol. 2007;13(13):1953–1961.PubMed
6.
Zurück zum Zitat Kalia N, Brown NJ, Wood RF, Pockley AG. Ketotifen abrogates local and systemic consequences of rat intestinal ischemia–reperfusion injury. J Gastroenterol Hepatol. 2005;20(7):1032–1038.PubMed Kalia N, Brown NJ, Wood RF, Pockley AG. Ketotifen abrogates local and systemic consequences of rat intestinal ischemia–reperfusion injury. J Gastroenterol Hepatol. 2005;20(7):1032–1038.PubMed
7.
Zurück zum Zitat Boisseau MR. Leukocyte involvement in the signs and symptoms of chronic venous disease. Perspectives for therapy. Clin Hemorheol Microcirc. 2007;37(3):277–290.PubMed Boisseau MR. Leukocyte involvement in the signs and symptoms of chronic venous disease. Perspectives for therapy. Clin Hemorheol Microcirc. 2007;37(3):277–290.PubMed
8.
Zurück zum Zitat Shoab SS, Porter J, Scurr JH, Coleridge-Smith PD. Endothelial activation response to oral micronized flavonoid therapy in patients with chronic venous disease. A prospective study. Eur J Vasc Endovasc Surg. 1999;17:313.CrossRefPubMed Shoab SS, Porter J, Scurr JH, Coleridge-Smith PD. Endothelial activation response to oral micronized flavonoid therapy in patients with chronic venous disease. A prospective study. Eur J Vasc Endovasc Surg. 1999;17:313.CrossRefPubMed
9.
Zurück zum Zitat Cospite M, Cospite V. Treatment of hemorrhoids with DAFLON 500 mg. Phlebology. 1992;7(suppl 2):53–56. Cospite M, Cospite V. Treatment of hemorrhoids with DAFLON 500 mg. Phlebology. 1992;7(suppl 2):53–56.
10.
Zurück zum Zitat Friesenecker B, Tsai AG, Allegra C, Intaglietta M. Oral administration of purified micronized flavonoid fraction suppresses leukocyte adhesion in ischemia–reperfusion injury: in vivo observations in the hamster skin fold. Int J Microcirc. 1994;14:50–55.CrossRef Friesenecker B, Tsai AG, Allegra C, Intaglietta M. Oral administration of purified micronized flavonoid fraction suppresses leukocyte adhesion in ischemia–reperfusion injury: in vivo observations in the hamster skin fold. Int J Microcirc. 1994;14:50–55.CrossRef
11.
Zurück zum Zitat Longchampt M. Protective effect of purified flavonoid fraction against reactive oxygen radicals. In vivo and in vitro study. Arzneimittelforschung/Drug Res. 1989;39:882–885. Longchampt M. Protective effect of purified flavonoid fraction against reactive oxygen radicals. In vivo and in vitro study. Arzneimittelforschung/Drug Res. 1989;39:882–885.
12.
Zurück zum Zitat Pehlivan M, Hazinedaroglu SM, Kayaoglu HA, et al. The effect of diosmin hesperidin on intestinal ischaemia–reperfusion injury. Acta Chir Belg. 2004;104(6):715–718.PubMed Pehlivan M, Hazinedaroglu SM, Kayaoglu HA, et al. The effect of diosmin hesperidin on intestinal ischaemia–reperfusion injury. Acta Chir Belg. 2004;104(6):715–718.PubMed
13.
Zurück zum Zitat Bouskela E, Donyo KA. Effects of oral administration of purified micronized flavonoid fraction on increased microvascular permeability induced by various agents and on ischemia/reperfusion in the hamster cheek pouch. Angiology. 1997;48:391–399.PubMed Bouskela E, Donyo KA. Effects of oral administration of purified micronized flavonoid fraction on increased microvascular permeability induced by various agents and on ischemia/reperfusion in the hamster cheek pouch. Angiology. 1997;48:391–399.PubMed
14.
Zurück zum Zitat Bouskela E, Cyrino FZ, Lerond L. Leukocyte adhesion after oxidant challenge in the hamster cheek pouch microcirculation. J Vasc Res. 1999;36:11–14.CrossRefPubMed Bouskela E, Cyrino FZ, Lerond L. Leukocyte adhesion after oxidant challenge in the hamster cheek pouch microcirculation. J Vasc Res. 1999;36:11–14.CrossRefPubMed
15.
Zurück zum Zitat Takase S, Delano FA, Lerond L, Bergan JJ, Schmid-Schönbein GW. Inflammation in chronic venous insufficiency. Is the problem insurmountable? J Vasc Res. 1999;36:3–10.CrossRefPubMed Takase S, Delano FA, Lerond L, Bergan JJ, Schmid-Schönbein GW. Inflammation in chronic venous insufficiency. Is the problem insurmountable? J Vasc Res. 1999;36:3–10.CrossRefPubMed
16.
Zurück zum Zitat Fiorini RN, Donovan JL, Rodwell D, et al. Short-term administration of (−)-epigallocatechin gallate reduces hepatic steatosis and protects against warm hepatic ischemia/reperfusion injury in steatotic mice. Liver Transpl. 2005;11(3):298–308.CrossRefPubMed Fiorini RN, Donovan JL, Rodwell D, et al. Short-term administration of (−)-epigallocatechin gallate reduces hepatic steatosis and protects against warm hepatic ischemia/reperfusion injury in steatotic mice. Liver Transpl. 2005;11(3):298–308.CrossRefPubMed
17.
Zurück zum Zitat Hu XM, Zhou MM, Hu XM, Zeng FD. Neuroprotective effects of scutellarin on rat neuronal damage induced by cerebral ischemia/reperfusion. Acta Pharmacol Sin. 2005;26(12):1454–1459.CrossRefPubMed Hu XM, Zhou MM, Hu XM, Zeng FD. Neuroprotective effects of scutellarin on rat neuronal damage induced by cerebral ischemia/reperfusion. Acta Pharmacol Sin. 2005;26(12):1454–1459.CrossRefPubMed
18.
Zurück zum Zitat Erel O. A novel automated method to measure total antioxidant response against potent free radical reactions. Clin Biochem. 2004;37:112–119.CrossRefPubMed Erel O. A novel automated method to measure total antioxidant response against potent free radical reactions. Clin Biochem. 2004;37:112–119.CrossRefPubMed
19.
Zurück zum Zitat Erel O. A new automated colorimetric method for measuring total oxidant status. Clin Biochem. 2005;38:1103–1111.CrossRefPubMed Erel O. A new automated colorimetric method for measuring total oxidant status. Clin Biochem. 2005;38:1103–1111.CrossRefPubMed
20.
Zurück zum Zitat Bolukbas C, Bolukbas FF, Horoz M, Aslan M, Celik H, Erel O. Increased oxidative stress associated with the severity of the liver disease in various forms of hepatitis B virus infection. BMC Infect Dis. 2005;5:95.CrossRefPubMed Bolukbas C, Bolukbas FF, Horoz M, Aslan M, Celik H, Erel O. Increased oxidative stress associated with the severity of the liver disease in various forms of hepatitis B virus infection. BMC Infect Dis. 2005;5:95.CrossRefPubMed
21.
Zurück zum Zitat Wei H, Frenkel K. Relationship of oxidative events and DNA oxidation in sencar mice to in vivo promoting activity of phorbol ester-type tumor promoters. Carcinogenesis. 1993;14:1195–1201.CrossRefPubMed Wei H, Frenkel K. Relationship of oxidative events and DNA oxidation in sencar mice to in vivo promoting activity of phorbol ester-type tumor promoters. Carcinogenesis. 1993;14:1195–1201.CrossRefPubMed
22.
Zurück zum Zitat Góth L. A simple method for determination of serum catalase activity and revision of reference range. Clin Chim Acta. 1991;196(2–3):143–151.CrossRefPubMed Góth L. A simple method for determination of serum catalase activity and revision of reference range. Clin Chim Acta. 1991;196(2–3):143–151.CrossRefPubMed
23.
Zurück zum Zitat Chiu CJ, McArdle AH, Brown R, Scott HJ, Gurd FN. Intestinal mucosal lesion in low-flow states. I. A morphological, hemodynamic, and metabolic reappraisal. Arch Surg. 1970;101(4):478–483.PubMed Chiu CJ, McArdle AH, Brown R, Scott HJ, Gurd FN. Intestinal mucosal lesion in low-flow states. I. A morphological, hemodynamic, and metabolic reappraisal. Arch Surg. 1970;101(4):478–483.PubMed
24.
Zurück zum Zitat Choukèr A, Schachtner T, Schauer R, et al. Effects of Pringle manoeuvre and ischaemic preconditioning on haemodynamic stability in patients undergoing elective hepatectomy: a randomized trial. Br J Anaesth. 2004;93(2):204–211.CrossRefPubMed Choukèr A, Schachtner T, Schauer R, et al. Effects of Pringle manoeuvre and ischaemic preconditioning on haemodynamic stability in patients undergoing elective hepatectomy: a randomized trial. Br J Anaesth. 2004;93(2):204–211.CrossRefPubMed
25.
Zurück zum Zitat Kim YI. Ischemia–reperfusion injury of the human liver during hepatic resection. J Hepatobiliary Pancreat Surg. 2003;10(3):195–199.CrossRefPubMed Kim YI. Ischemia–reperfusion injury of the human liver during hepatic resection. J Hepatobiliary Pancreat Surg. 2003;10(3):195–199.CrossRefPubMed
26.
Zurück zum Zitat Sánchez-Patán F, Aller MA, Cuellar C, et al. Mast cell inhibition by ketotifen reduces splanchnic inflammatory response in a portal hypertension model in rats. Exp Toxicol Pathol. 2008;60(4–5):347–355.CrossRefPubMed Sánchez-Patán F, Aller MA, Cuellar C, et al. Mast cell inhibition by ketotifen reduces splanchnic inflammatory response in a portal hypertension model in rats. Exp Toxicol Pathol. 2008;60(4–5):347–355.CrossRefPubMed
27.
Zurück zum Zitat Wu B, Fujise T, Iwakiri R, et al. Venous congestion induces mucosal apoptosis via tumor necrosis factor-alpha-mediated cell death in the rat small intestine. J Gastroenterol. 2004;39(11):1120–1122.CrossRef Wu B, Fujise T, Iwakiri R, et al. Venous congestion induces mucosal apoptosis via tumor necrosis factor-alpha-mediated cell death in the rat small intestine. J Gastroenterol. 2004;39(11):1120–1122.CrossRef
28.
Zurück zum Zitat Carden DL, Granger DN. Pathophysiology of ischaemia–reperfusion injury. J Pathol. 2000;190(3):255–266.CrossRefPubMed Carden DL, Granger DN. Pathophysiology of ischaemia–reperfusion injury. J Pathol. 2000;190(3):255–266.CrossRefPubMed
29.
Zurück zum Zitat Rahat MA, Lahat N, Smollar J, Brod V, Kinarty A, Bitterman H. Divergent effects of ischemia/reperfusion and nitric oxide donor on TNFalpha mRNA accumulation in rat organs. Shock. 2001;15(4):312–317.CrossRefPubMed Rahat MA, Lahat N, Smollar J, Brod V, Kinarty A, Bitterman H. Divergent effects of ischemia/reperfusion and nitric oxide donor on TNFalpha mRNA accumulation in rat organs. Shock. 2001;15(4):312–317.CrossRefPubMed
30.
Zurück zum Zitat Ozacmak VH, Sayan H, Arslan SO, Altaner S, Aktas RG. Protective effect of melatonin on contractile activity and oxidative injury induced. Life Sci. 2005;76(14):1575–1588.CrossRefPubMed Ozacmak VH, Sayan H, Arslan SO, Altaner S, Aktas RG. Protective effect of melatonin on contractile activity and oxidative injury induced. Life Sci. 2005;76(14):1575–1588.CrossRefPubMed
31.
Zurück zum Zitat Unlü A, Sucu N, Tamer L, et al. Effects of Daflon on oxidative stress induced by hindlimb ischemia/reperfusion. Pharmacol Res. 2003;48:11–15.PubMed Unlü A, Sucu N, Tamer L, et al. Effects of Daflon on oxidative stress induced by hindlimb ischemia/reperfusion. Pharmacol Res. 2003;48:11–15.PubMed
32.
Zurück zum Zitat Simsek M, Burak F, Taskin O. Effects of micronized purified flavonoid fraction (Daflon) on pelvic pain in women with laparoscopically diagnosed pelvic congestion syndrome: a randomized crossover trial. Clin Exp Obstet Gynecol. 2007;34(2):96–98.PubMed Simsek M, Burak F, Taskin O. Effects of micronized purified flavonoid fraction (Daflon) on pelvic pain in women with laparoscopically diagnosed pelvic congestion syndrome: a randomized crossover trial. Clin Exp Obstet Gynecol. 2007;34(2):96–98.PubMed
33.
Zurück zum Zitat Karabulut AB, Kirimlioglu V, Kirimlioglu H, Yilmaz S, Isik B, Isikgil O. Protective effects of resveratrol on spleen and ileum in rats subjected to ischemia–reperfusion. Transpl Proc. 2006;38(2):375–377.CrossRef Karabulut AB, Kirimlioglu V, Kirimlioglu H, Yilmaz S, Isik B, Isikgil O. Protective effects of resveratrol on spleen and ileum in rats subjected to ischemia–reperfusion. Transpl Proc. 2006;38(2):375–377.CrossRef
34.
Zurück zum Zitat Hossain MA, Izuishi K, Tokuda M, Izumori K, Maeta H. D-Allose has a strong suppressive effect against ischemia/reperfusion injury: a comparative study with allopurinol and superoxide dismutase. J Hepatobiliary Pancreat Surg. 2004;11(3):181–189.CrossRefPubMed Hossain MA, Izuishi K, Tokuda M, Izumori K, Maeta H. D-Allose has a strong suppressive effect against ischemia/reperfusion injury: a comparative study with allopurinol and superoxide dismutase. J Hepatobiliary Pancreat Surg. 2004;11(3):181–189.CrossRefPubMed
35.
Zurück zum Zitat Yildiz F, Coban S, Terzi A, et al. Nigella sativa relieves the deleterious effects of ischemia reperfusion injury on liver. World J Gastroenterol. 2008;14(33):5204–5209.CrossRefPubMed Yildiz F, Coban S, Terzi A, et al. Nigella sativa relieves the deleterious effects of ischemia reperfusion injury on liver. World J Gastroenterol. 2008;14(33):5204–5209.CrossRefPubMed
Metadaten
Titel
Purified Micronized Flavonoid Fraction Ameliorates the Injury of Spleen and Ileum Secondary to Hepatic Ischemia–Reperfusion in Rats
verfasst von
Fahrettin Yildiz
Alpaslan Terzi
Sacit Coban
Muharrem Bitiren
Hakim Celik
Nurten Aksoy
Mustafa Kemal Ozdogan
Hale Cakir
Publikationsdatum
01.08.2010
Verlag
Springer US
Erschienen in
Digestive Diseases and Sciences / Ausgabe 8/2010
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-009-1018-7

Weitere Artikel der Ausgabe 8/2010

Digestive Diseases and Sciences 8/2010 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Hodgkin Lymphom: BrECADD-Regime übertrifft die Erwartungen

05.06.2024 ASCO 2024 Kongressbericht

Das Kombinationsregime BrECADD mit Brentuximab vedotin ermöglichte in der Studie HD21 beim fortgeschrittenen klassischen Hodgkin-Lymphom eine unerwartet hohe progressionsfreie Überlebensrate von 94,3% nach vier Jahren. Gleichzeitig war das Regime besser tolerabel als der bisherige Standard eBEACOPP.

Antikörper-Drug-Konjugat verdoppelt PFS bei Multiplem Myelom

05.06.2024 ASCO 2024 Nachrichten

Zwei Phase-3-Studien deuten auf erhebliche Vorteile des Antikörper-Wirkstoff-Konjugats Belantamab-Mafodotin bei vorbehandelten Personen mit Multiplem Myelom: Im Vergleich mit einer Standard-Tripeltherapie wurde das progressionsfreie Überleben teilweise mehr als verdoppelt.

Neuer TKI gegen CML: Höhere Wirksamkeit, seltener Nebenwirkungen

05.06.2024 Chronische myeloische Leukämie Nachrichten

Der Tyrosinkinasehemmer (TKI) Asciminib ist älteren Vertretern dieser Gruppe bei CML offenbar überlegen: Personen mit frisch diagnostizierter CML entwickelten damit in einer Phase-3-Studie häufiger eine gut molekulare Response, aber seltener ernste Nebenwirkungen.

Hereditäres Angioödem: Tablette könnte Akuttherapie erleichtern

05.06.2024 Hereditäres Angioödem Nachrichten

Medikamente zur Bedarfstherapie bei hereditärem Angioödem sind bisher nur als Injektionen und Infusionen verfügbar. Der Arzneistoff Sebetralstat kann oral verabreicht werden und liefert vielversprechende Daten.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.